Differential mucin expression by respiratory syncytial virus and human metapneumovirus infection in human epithelial cells

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Baños Lara, Ma Del Rocío ^a   Piao, Boyang ^a   Guerrero Plata, Antonieta ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUCIN; MUCIN 1; MUCIN 15; MUCIN 2; MUCIN 20; MUCIN 21; MUCIN 22; MUCIN 5B; MUCIN 8; UNCLASSIFIED DRUG; MEMBRANE PROTEIN; MUC1 PROTEIN, HUMAN; MUC15 PROTEIN, HUMAN; MUC2 PROTEIN, HUMAN; MUC20 PROTEIN, HUMAN; MUC21 PROTEIN, HUMAN; MUC5B PROTEIN, HUMAN; MUC8 PROTEIN, HUMAN;

A549 CELL LINE; ARTICLE; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN METAPNEUMOVIRUS INFECTION; IMMUNE RESPONSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY SYNCYTIAL VIRUS INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS STRAIN; ANIMAL; CELL LINE; GENETICS; HUMAN RESPIRATORY SYNCYTIAL VIRUS; METABOLISM; METAPNEUMOVIRUS; MOUSE; PHYSIOLOGY; VIROLOGY;

HUMAN METAPNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS;

ANIMALS; CELL LINE; EPITHELIAL CELLS; HUMANS; MEMBRANE GLYCOPROTEINS; METAPNEUMOVIRUS; MICE; MUCIN-1; MUCIN-2; MUCIN-5B; MUCINS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN;

EID: 84929377440     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/347292     Document Type: Article

References (35)

1. M. C. Rose, "Mucins: structure, function, and role in pulmonary diseases," American Journal of Physiology - Lung Cellular and Molecular Physiology, vol. 263, no. 4, pp. L413-L429, 1992.
2. C. M. Evans and J. S. Koo, "Airway mucus: the good, the bad, the sticky," Pharmacology and Therapeutics, vol. 121, no. 3, pp. 332-348, 2009.
3. S. K. Linden, P. Sutton, N. G. Karlsson, V. Korolik, and M. A. McGuckin, "Mucins in the mucosal barrier to infection," Mucosal Immunology, vol. 1, no. 3, pp. 183-197, 2008.
4. M. Hijikata, I.Matsushita, G. Tanaka et al., "Molecular cloning of two novelmucin-like genes in the disease-susceptibility locus for diffuse panbronchiolitis," Human Genetics, vol. 129, no. 2,pp. 117-128, 2011.
5. H.-P. Hauber, S. C. Foley, and Q. Hamid, "Mucin overproduction in chronic inflammatory lung disease," Canadian Respiratory Journal, vol. 13, no. 6, pp. 327-335, 2006.
6. E. A. Rakha, R. W. G. Boyce, D. A. El-Rehimet al., "Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer," Modern Pathology, vol. 18, no. 10, pp. 1295-1304, 2005.
7. S. C. Chauhan, D. Kumar, and M. Jaggi, "Mucins in ovarian cancer diagnosis and therapy," Journal of Ovarian Research, vol. 2, no. 1, article 21, 2009.
8. W. P. Glezen, L. H. Taber, A. L. Frank, and J. A. Kasel, "Risk of primary infection and reinfection with respiratory syncytial virus," American Journal of Diseases of Children, vol. 140, no. 6, pp. 543-546, 1986.
9. G. Boivin, G. de Serres, S. Côté et al., "Human metapneumovirus infections in hospitalized children," Emerging Infectious Diseases, vol. 9, no. 6, pp. 634-640, 2003.
10. F. Esper, D. Boucher, C. Weibel, R. A. Martinello, and J. S. Kahn, "Human metapneumovirus infection in the United States: clinical manifestations associated with a newly emerging respiratory infection in children," Pediatrics, vol. 111, no. 6, pp. 1407-1410, 2003.
11. A. R. Falsey, D. Erdman, L. J. Anderson, and E. E. Walsh, "Human metapneumovirus infections in young and elderly adults," Journal of InfectiousDiseases, vol. 187, no. 5,pp. 785-790, 2003.
12. J. V. Williams, P. A. Harris, S. J. Tollefson et al., "Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children,"The New England Journal of Medicine, vol. 350, no. 5, pp. 443-450, 2004.
13. F. R. Laham, V. Israele, J. M. Casellas et al., "Differential production of inflammatory cytokines in primary infection with human metapneumovirus and with other common respiratory viruses of infancy," The Journal of Infectious Diseases, vol. 189, no. 11, pp. 2047-2056, 2004.
14. G. A. Melendi, F. R. Laham, A. C. Monsalvo et al., "Cytokine profiles in the respiratory tract during primary infection with human metapneumovirus, respiratory syncytial virus, or influenza virus in infants," Pediatrics, vol. 120, no. 2, pp. e410-e415, 2007.
15. P. Joshi, A. Shaw, A. Kakakios, and D. Isaacs, "Interferongamma levels in nasopharyngeal secretions of infants with respiratory syncytial virus and other respiratory viral infections," Clinical and Experimental Immunology, vol. 131, no. 1, pp. 143-147, 2003.
16. A. Guerrero-Plata, S. Baron, J. S. Poast, P. A. Adegboyega, A. Casola, and R. P. Garofalo, "Activity and regulation of alpha interferon in respiratory syncytial virus and human metapneumovirus experimental infections," Journal of Virology, vol. 79, no. 16, pp. 10190-10199, 2005.
17. K. Chakraborty, Z. Zhou, N. Wakamatsu, and A. Guerrero-Plata, "Interleukin-12p40 modulates human metapneumovirus-induced pulmonary disease in an acute mouse model of infection," PLoS ONE, vol. 7, no. 5,Article ID e37173, 2012.
18. A. L. Kisch and K. M. Johnson, "A plaque assay for respiratory syncytial virus," Proceedings of the Society for Experimental Biology and Medicine, vol. 112, pp. 583-589, 1963.
19. M.D. R. Baños-Lara, A. Ghosh, andA.Guerrero-Plata, "Critical role of MDA5 in the interferon response induced by human metapneumovirus infection in dendritic cells and in vivo," Journal of Virology, vol. 87, no. 2, pp. 1242-1251, 2013.
20. B. D. Persson, A. B. Jaffe, R. Fearns, and H. Danahay, "Respiratory syncytial virus can infect basal cells and alter human airway epithelial differentiation," PLoS ONE, vol. 9, Article IDe102368, 2014.
21. C. Ehre, E. N.Worthington, R. M. Liesman et al., "Overexpressingmousemodel demonstrates the protective role ofMuc5ac in the lungs," Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 41, pp. 16528-16533, 2012.
22. V. Shankar, P. Pichan, R. L. Eddy Jr. et al., "Chromosomal localization of a human mucin gene (MUC8) and cloning of the cDNA corresponding to the carboxy terminus," American Journal of Respiratory Cell and Molecular Biology, vol. 16, no. 3, pp. 232-241, 1997.
23. C. H. Bae, B. S. Jeon, Y. S. Choi, S. Y. Song, and Y. D. Kim, "Delphinidin inhibits LPS-induced MUC8 and MUC5B expression through toll-like receptor 4-mediated ERK1/2 and p38 MAPK in human airway epithelial cells," Clinical & Experimental Otorhinolaryngology, vol. 7, no. 3, pp. 198-204, 2014.
24. S.-H. Shin, M.-K. Ye, and J.-K. Kim, "Effects of fungi and eosinophils on mucin gene expression in rhinovirus-infected nasal epithelial cells," Allergy, Asthma & Immunology Research, vol. 6, no. 2, pp. 149-155, 2014.
25. D. Inoue, M. Yamaya, H. Kubo et al., "Mechanisms of mucin production by rhinovirus infection in cultured human airway epithelial cells," Respiratory Physiology & Neurobiology, vol. 154, no. 3, pp. 484-499, 2006.
26. K. S. Song, J.-K. Seong, K. C. Chung et al., "Induction of MUC8 gene expression by interleukin-1α is mediated by a sequential ERK MAPK/RSK1/CREB cascade pathway in human airway epithelial cells," The Journal of Biological Chemistry, vol. 278, no. 37, pp. 34890-34896, 2003.
27. K.-N. Cho, J. Y. Choi, C.-H. Kim et al., "Prostaglandin E2 induces MUC8 gene expression via a mechanism involving ERK MAPK/RSK1/cAMP response element binding protein activation in human airway epithelial cells," Journal of Biological Chemistry, vol. 280, no. 8, pp. 6676-6681, 2005.
28. K. S. Song, K. Kim, K. C. Chung, J. H. Seol, and J.-H. Yoon, "Interaction of SOCS3 with NonO attenuates IL-1α-dependent MUC8 gene expression," Biochemical and Biophysical Research Communications, vol. 377, no. 3, pp. 946-951, 2008.
29. Y. Li, D. L. Dinwiddie, K. S. Harrod, Y. Jiang, and K. C. Kim, "Anti-inflammatory effect ofMUC1 during respiratory syncytial virus infection of lung epithelial cells in vitro,"American Journal of Physiology: Lung Cellular and Molecular Physiology, vol. 298, no. 4, pp. L558-L563, 2010.
30. A. Guerrero-Plata, A. Casola, G. Suarez et al., "Differential response of dendritic cells to human metapneumovirus and respiratory syncytial virus,"TheAmerican Journal of Respiratory Cell and Molecular Biology, vol. 34, no. 3, pp. 320-329, 2006.
31. B. Huck, D. Neumann-Haefelin, A. Schmitt-Graeff et al., "Human metapneumovirus induces more severe disease and stronger innate immune response in BALB/c mice as compared with respiratory syncytial virus," Respiratory Research, vol. 8, article 6, 2007.
32. R. Banos-LaraMdel, L. Harvey, A.Mendoza et al., "Impact and regulation of lambda interferon response in human metapneumovirus infection," Journal of Virology, vol. 89, pp. 730-742, 2015.
33. A. Guerrero-Plata, A. Casola, and R. P. Garofalo, "Human metapneumovirus induces a profile of lung cytokines distinct from that of respiratory syncytial virus," Journal of Virology, vol. 79, no. 23, pp. 14992-14997, 2005.
34. D. Kolli, M. R. Gupta, E. Sbrana et al., "Alveolar macrophages contribute to the pathogenesis of hMPV infection while protecting against respiratory syncytial virus infection," American Journal of Respiratory Cell and Molecular Biology, vol. 51, no. 4, pp. 502-514, 2014.
35. V. Ditt, J. Lüsebrink, R. L. Tillmann, V. Schildgen, and O. Schildgen, "Respiratory infections by HMPV and RSV are clinically indistinguishable but induce different host response in aged individuals," PLoS ONE, vol. 6, no. 1, Article ID e16314, 2011.